CN106399244B - 一种nk细胞培养基 - Google Patents
一种nk细胞培养基 Download PDFInfo
- Publication number
- CN106399244B CN106399244B CN201610961055.8A CN201610961055A CN106399244B CN 106399244 B CN106399244 B CN 106399244B CN 201610961055 A CN201610961055 A CN 201610961055A CN 106399244 B CN106399244 B CN 106399244B
- Authority
- CN
- China
- Prior art keywords
- culture medium
- cells
- cell culture
- medium
- cultured
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000000822 natural killer cell Anatomy 0.000 title claims abstract description 70
- 239000006143 cell culture medium Substances 0.000 title claims abstract description 30
- 229920001184 polypeptide Polymers 0.000 claims abstract description 10
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 10
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 10
- 239000007640 basal medium Substances 0.000 claims abstract description 5
- 239000002609 medium Substances 0.000 claims description 14
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 claims description 2
- 239000012980 RPMI-1640 medium Substances 0.000 claims description 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 230000002147 killing effect Effects 0.000 abstract description 19
- 210000004881 tumor cell Anatomy 0.000 abstract description 13
- 241000190633 Cordyceps Species 0.000 abstract description 4
- 150000004676 glycans Chemical class 0.000 abstract description 4
- 210000002381 plasma Anatomy 0.000 abstract description 4
- 229920001282 polysaccharide Polymers 0.000 abstract description 4
- 239000005017 polysaccharide Substances 0.000 abstract description 4
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 abstract description 3
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 abstract description 2
- 229910052708 sodium Inorganic materials 0.000 abstract 1
- 239000011734 sodium Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
- 230000035755 proliferation Effects 0.000 description 13
- 230000000694 effects Effects 0.000 description 11
- 239000001963 growth medium Substances 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 8
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 6
- 238000004113 cell culture Methods 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- 238000012258 culturing Methods 0.000 description 6
- 229910002092 carbon dioxide Inorganic materials 0.000 description 5
- 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 5
- 102000000588 Interleukin-2 Human genes 0.000 description 4
- 108010002350 Interleukin-2 Proteins 0.000 description 4
- 150000001413 amino acids Chemical group 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 102000004127 Cytokines Human genes 0.000 description 3
- 108090000695 Cytokines Proteins 0.000 description 3
- 239000001569 carbon dioxide Substances 0.000 description 3
- 238000009169 immunotherapy Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000001502 supplementing effect Effects 0.000 description 3
- DHBKYZYFEXXUAK-ONGXEEELSA-N Ala-Phe-Gly Chemical compound OC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)C)CC1=CC=CC=C1 DHBKYZYFEXXUAK-ONGXEEELSA-N 0.000 description 2
- YXVAESUIQFDBHN-SRVKXCTJSA-N Asn-Phe-Ser Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(O)=O YXVAESUIQFDBHN-SRVKXCTJSA-N 0.000 description 2
- YRBGRUOSJROZEI-NHCYSSNCSA-N Asp-His-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C(C)C)C(O)=O YRBGRUOSJROZEI-NHCYSSNCSA-N 0.000 description 2
- KIHRUISMQZVCNO-ZLUOBGJFSA-N Cys-Asp-Asp Chemical compound SC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O KIHRUISMQZVCNO-ZLUOBGJFSA-N 0.000 description 2
- SMEYEQDCCBHTEF-FXQIFTODSA-N Cys-Pro-Ala Chemical compound [H]N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O SMEYEQDCCBHTEF-FXQIFTODSA-N 0.000 description 2
- YNJBLTDKTMKEET-ZLUOBGJFSA-N Cys-Ser-Ser Chemical compound SC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O YNJBLTDKTMKEET-ZLUOBGJFSA-N 0.000 description 2
- LCRDMSSAKLTKBU-ZDLURKLDSA-N Gly-Ser-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)CN LCRDMSSAKLTKBU-ZDLURKLDSA-N 0.000 description 2
- JBCLFWXMTIKCCB-UHFFFAOYSA-N H-Gly-Phe-OH Natural products NCC(=O)NC(C(O)=O)CC1=CC=CC=C1 JBCLFWXMTIKCCB-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- AYPMIIKUMNADSU-IHRRRGAJSA-N Phe-Arg-Asn Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(O)=O AYPMIIKUMNADSU-IHRRRGAJSA-N 0.000 description 2
- IXZHZUGGKLRHJD-DCAQKATOSA-N Ser-Leu-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O IXZHZUGGKLRHJD-DCAQKATOSA-N 0.000 description 2
- CKDXFSPMIDSMGV-GUBZILKMSA-N Ser-Pro-Val Chemical compound [H]N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(O)=O CKDXFSPMIDSMGV-GUBZILKMSA-N 0.000 description 2
- MHCLIYHJRXZBGJ-AAEUAGOBSA-N Trp-Gly-Cys Chemical compound N[C@@H](CC1=CNC2=CC=CC=C12)C(=O)NCC(=O)N[C@@H](CS)C(=O)O MHCLIYHJRXZBGJ-AAEUAGOBSA-N 0.000 description 2
- 108010024078 alanyl-glycyl-serine Proteins 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000004663 cell proliferation Effects 0.000 description 2
- 239000002872 contrast media Substances 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 108010081551 glycylphenylalanine Proteins 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 229920001917 Ficoll Polymers 0.000 description 1
- 102000013275 Somatomedins Human genes 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 210000004443 dendritic cell Anatomy 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000005934 immune activation Effects 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 229940088592 immunologic factor Drugs 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0646—Natural killers cells [NK], NKT cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/2302—Interleukin-2 (IL-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/50—Cell markers; Cell surface determinants
- C12N2501/515—CD3, T-cell receptor complex
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/90—Polysaccharides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/998—Proteins not provided for elsewhere
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610961055.8A CN106399244B (zh) | 2016-10-28 | 2016-10-28 | 一种nk细胞培养基 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610961055.8A CN106399244B (zh) | 2016-10-28 | 2016-10-28 | 一种nk细胞培养基 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106399244A CN106399244A (zh) | 2017-02-15 |
CN106399244B true CN106399244B (zh) | 2020-02-21 |
Family
ID=58013733
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610961055.8A Active CN106399244B (zh) | 2016-10-28 | 2016-10-28 | 一种nk细胞培养基 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106399244B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107418931A (zh) * | 2017-08-17 | 2017-12-01 | 重庆斯德姆生物技术有限公司 | 一种提高活率的细胞培养液 |
CN109234161A (zh) * | 2018-09-25 | 2019-01-18 | 深圳市宝迪生物工程有限公司 | 一种干细胞培养液用的震荡装置及其使用方法 |
CN111718399A (zh) * | 2020-06-30 | 2020-09-29 | 南京赛尔健生物技术有限公司 | 一种多肽及用于nk细胞培养、制备nk细胞培养基的用途 |
CN111620932A (zh) * | 2020-06-30 | 2020-09-04 | 南京赛尔健生物技术有限公司 | 一种多肽及在促进nk细胞增殖和提高其对肿瘤细胞杀伤力方面的应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104894065A (zh) * | 2015-07-09 | 2015-09-09 | 广州赛莱拉干细胞科技股份有限公司 | 一种nk细胞培养基及nk细胞的培养方法 |
-
2016
- 2016-10-28 CN CN201610961055.8A patent/CN106399244B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104894065A (zh) * | 2015-07-09 | 2015-09-09 | 广州赛莱拉干细胞科技股份有限公司 | 一种nk细胞培养基及nk细胞的培养方法 |
Non-Patent Citations (5)
Title |
---|
A peptide derived from the C-terminal part of a plant cysteine protease folds into a stack of two b-hairpins, a scaffold present in the emerging family of granulin-like growth factors;D. Tolkatchev等;《J. Pept. Res.》;20011231;第57卷(第3期);227-233 * |
Chain A, The Solution Structure Of A 35-Residue Fragment From The GranulinEPITHELIN-Like Subdomain Of Rice Oryzain Beta (Rob 382-416 (C398s,C399s,C407s,C413s)),PDB: 1FWO_A,35aa linea;D. Tolkatchev等;《NCBI genbank》;20121010;1 * |
中药多糖的抗癌研究与临床应用进展;郭随章;《医药导报》;20041130;第23卷(第11期);847-848 * |
家蚕蛹虫草对小鼠免疫调节的影响;贡成良等;《蚕业科学》;20041231;第30卷(第4期);386-389 * |
蛹虫草菌粉对肝硬化患者T细胞免疫调节作用的研究;朱铁英等;《中国医药指南》;20131231;第11卷(第35期);202-203 * |
Also Published As
Publication number | Publication date |
---|---|
CN106399244A (zh) | 2017-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106399244B (zh) | 一种nk细胞培养基 | |
Bernareggi et al. | Development of innate immune cells from human pluripotent stem cells | |
US20130157364A1 (en) | Medium composition for culturing self-activated lymphocytes and method for culturing self-activated lymphocytes using same | |
JP2022162093A (ja) | CD8α+β+細胞傷害性T細胞の製造方法 | |
CN106581668B (zh) | 一种抗原表位肽组合物及其应用 | |
JP4870432B2 (ja) | 細胞傷害性リンパ球の製造方法 | |
JPWO2020223537A5 (zh) | ||
CN105219708A (zh) | 免疫细胞培养试剂盒、免疫细胞培养方法和应用 | |
Van den Bergh et al. | Characterization of interleukin‐15‐transpresenting dendritic cells for clinical use | |
EP4393958A1 (en) | Long-acting recombinant human interleukin-2 fusion protein, and preparation method therefor and application thereof | |
CN112048480A (zh) | 一种基于电转制备nk样细胞的方法 | |
CN110669145A (zh) | 三聚体trail融合蛋白基因修饰间充质干细胞的方法及其用途 | |
CN108251370B (zh) | 非细胞来源的多肽致敏的dc-cik细胞、其构建方法及应用 | |
CN105219723A (zh) | 一种用于激活胃癌特异性免疫反应的试剂盒 | |
CN114957441B (zh) | 转基因nk细胞及其在抗肿瘤药物中的应用 | |
Guo et al. | Manufacturing CAR-NK against tumors: Who is the ideal supplier? | |
CN116970561B (zh) | 一种工程化的γδT细胞及其制备方法 | |
CN112010944B (zh) | 一种肽及体外扩增cik细胞的方法 | |
EP4104840A1 (en) | Optimization of chimeric antigen receptor | |
CN107188959B (zh) | 抗原肽t790m-6及其在制备治疗非小细胞肺癌的药物中的应用 | |
CN107188958B (zh) | 抗原肽t790m-5及其在制备治疗非小细胞肺癌的药物中的应用 | |
RU2639514C1 (ru) | Способ получения антиген-специфических цитотоксических клеток, обладающих противоопухолевой цитотоксической активностью против клеток немелкоклеточного рака легкого | |
CN110139875A (zh) | Col14a1衍生的肿瘤抗原多肽及其应用 | |
KR101739659B1 (ko) | 면역질환 치료 효능을 갖는 Grim19이 과발현된 중간엽줄기세포 및 이의 용도 | |
Kumar et al. | CHIMERIC ANTIGEN RECEPTOR (CAR) T CELL THERAPY FOR ASPERGILLOSIS. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240511 Address after: Building B505, Yinxing Zhijie Phase II, No. 1301-76, Guanlan Community, Guanlan Street, Longhua District, Shenzhen City, Guangdong Province, 518110 Patentee after: SHENZHEN BAODI BIOLOGICAL ENGINEERING Co.,Ltd. Country or region after: China Address before: Room 504, Administrative and Business District, Binhai Park, Nantong City, Jiangsu Province, 226399 Patentee before: NANTONG BAOTONGKANG BIOLOGY ENGINEERING STOCK Co.,Ltd. Country or region before: China |
|
TR01 | Transfer of patent right |